NCT06528327

Brief Summary

Dental implant's surface properties significantly influence both biological and mechanical integration. Surface bio-treatment could accelerate and enhance bone regeneration, ensuring successful implantation. therefore, this study compares bone densification, primary and secondary stability, wound healing, and pain intensity between pre-coated antimicrobial surfaces of dental implants versus non-coated surfaces in controlled type 2 diabetic patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 26, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 30, 2024

Completed
Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

1.6 years

First QC Date

July 17, 2024

Last Update Submit

July 25, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • change in implant stability

    implant stability will be assessed using Osstell device

    up to 4 months

  • change in pain intensity

    pain was assessed using visual analogue scale that ranges from 0 (No pain) to 10 (untolerated pain)

    1st,3rd, and 7th days

  • Wound Healing score

    Landry healing index was used; 1. Very poor Tissue color: ≥50% of gingiva red, Response to palpation: Bleeding, Granulation tissue:Present, Incision margin: Not epithelialized, with loss ofepithelium beyond incision margin, Suppuration: Present 2. Poor Tissue color: ≥50% of gingiva red, Response to palpation: Bleeding, Granulation tissue: Present, Incision margin: Not epithelialized, with connective tissue exposed 3. Good Tissue colour: ≥25% and\<50% of gingiva red, Response to palpation: No bleeding, Granulation tissue: None, Incision margin: No connective tissue exposed 4. Very good Tissue colour: \<25% of gingiva red, Response to palpation: No bleeding, Granulation tissue: None, Incision margin: No connective tissue exposed 5. Excellent Tissue color: All tissues pink, Response to palpation: No bleeding, Granulation tissue: None, Incision margin: No connective tissue expose

    1st,3rd, and 7th days,14th day

Secondary Outcomes (2)

  • Post operative complications

    6 months

  • Change in bone density

    up to 4 months

Study Arms (2)

Pre coated surface implants

EXPERIMENTAL
Other: Pre coated impants

Non coated surface implants

ACTIVE COMPARATOR
Other: Non coated implant surface

Interventions

Pre coated impants with microstructured bioactive antimicrobial coating with double threading for higher bone-to-implant contact and faster bone gathering on the surface.

Pre coated surface implants

Non-coated implant with double threading for higher bone-to-implant contact and faster bone gathering on the surface.

Non coated surface implants

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adequate interproximal space.
  • Adequate interocclusal space.
  • Adequate anatomical location, accessibility, and visualization for easy surgical implant placement.
  • Both genders.
  • Controlled medical condition

You may not qualify if:

  • Presence of parafunctional dependency as bruxism.
  • Adjacent pathosis near the implant site.
  • Patient under radiotherapy targeting the head and neck.
  • Heavy smokers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria Faculty of Dentistry

Alexandria, Egypt

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Split Mouth Design
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Lecturer of Dental Public Health and biostatistical consultanat

Study Record Dates

First Submitted

July 17, 2024

First Posted

July 30, 2024

Study Start

June 26, 2022

Primary Completion

February 12, 2024

Study Completion

February 12, 2024

Last Updated

July 30, 2024

Record last verified: 2024-07

Locations